ANPEP and neoplasm: Interestingly, we have observed major tumor blood flow reductions in MRI as measured by k-trans and VVF also in patients with CD13 positivity (intensity scores 2; for methodology see ref. 20) of the tumor vasculature only, with the tumor cells being CD13-negative (Supplementary Figure S3).